Loading...

RAPP RAPPORT THERAPEUTICS INC Capital Structure Changes 8-K Filing

RPPR

RPP

RAPPORT THERAPEUTICS INC

(RAPP)

2026 8-K

Financial Results Update

Seizure Reduction Results

Financial Results Update

Stock Offering Announcement

Program Expansion

Financial Results Announced

Stock Offering Update

Sales Agreement Termination

Positive Clinical Results

Financial Statements

Product Expansion

Financial Statements

Financial Results

Management Update

Financial Results

External Links:

On January 7, 2026, Rapport Therapeutics filed to register the sale of up to $110 million in common stock through Leerink Partners and Cantor Fitzgerald, with no shares sold yet under this agreement.

AI Assistant

RAPPORT THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.